Effects omega-3 fatty acid supplementation in the treatment of diabetes
Phase 2
- Conditions
- Diabetic nephropathy.Insulin-dependent diabetes mellitus
- Registration Number
- IRCT201502255623N36
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with diabetic nephropathy aged 45 to 85 years.
Proteinuria level>0.3 g/24 h, with or without elevation of serum creatinine levels
Exclusion Criteria
The intake of omega-3 fatty acid supplements within 3 months
Patients with uncontrolled diabetes
The current use of warfarin
Malignancy and/or liver cirrhosis.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: Baseline and End-of-trial. Method of measurement: Calculation using HOMA formula.;Insulin. Timepoint: Baseline and End-of-trial. Method of measurement: ELISA kit.
- Secondary Outcome Measures
Name Time Method